LONDON, May 1, 2019 /PRNewswire/ -- The global biosimilars and follow-on biologics market is estimated to have reached $10.7bn in 2018 and expected to grow at a CAGR of 5.4% in the first half of the forecast period. The market is dominated by Biosimilar Monoclonal Antibodies, this...
from PR Newswire: https://prn.to/2ZMfQCm
No comments:
Post a Comment